The Company is a party to operating leases for its corporate offices, laboratory space and vehicles. | | | Six months ended June 30, | | | (in thousands) | | 2026 | | | 2025 | | | | | | | | | | | The components of lease expense were as follows: | | | | | | | | Operating leases expenses | | $ | 139 | | | $ | 154 | | | Supplemental consolidated cash flow information related to operating leases follows: | | | | | | | | | | Cash used in operating activities | | $ | 139 | | | $ | 163 | | | Non-cash activity: | | | | | | | | | | Right of use assets obtained in exchange for new operating lease liabilities | | $ | 137 | | | $ | 43 | | ENLIVEX LTD. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS JUNE 30, 2026 (UNAUDITED) Supplemental information related to operating leases, including location of amounts reported in the accompanying consolidated balance sheets, follows: | | | June 30, | | | December 31, | | | (in thousands) | | 2026 | | | 2025 | | | | | | | | | | Other assets - ROU assets | | $ | 1,245 | | | $ | 1,108 | | | Accumulated amortization | | | 656 | | | | 531 | | | Operating lease ROU assets, net | | $ | 589 | | | $ | 577 | | | | | June 30, | | | December 31, | | | (in thousands) | | 2026 | | | 2025 | | | | | | | | | | Lease liabilities – current - Accounts payable and accrued liabilities | | $ | 296 | | | $ | 258 | | | Lease liabilities – noncurrent | | | 371 | | | | 383 | | | Total operating lease liabilities | | $ | 667 | | | $ | 641 | | | Weighted average remaining lease term in years | | | 2.4 | | | | 1.54 | | | Weighted average annual discount rate | | | 4.9 | % | | | 4.9 | % |
|